Hyper-Crosslinked Carbohydrate Polymer for Repair of Critical-Sized Bone Defects

Plamena M. Koleva, James H. Keefer, Alexandria M. Ayala, Isabela Lorenzo, Christine E. Han, Kristen Pham, Stacy E. Ralston, Kee D. Kim, Charles C. Lee

Research output: Contribution to journalArticle

Abstract

This study evaluated the safety and efficacy of a novel hyper-crosslinked carbohydrate polymer (HCCP) for the repair of critical-sized bone defects in comparison to two alternative treatments: autologous bone and poly(lactide-co-glycolide) with hyaluronic acid (PLGA/HA). Bilateral critical-sized defects were created in the lateral femoral condyles of skeletally mature New Zealand White rabbits, and they were subsequently implanted with HCCP, PLGA/HA, or autologous bone in a randomized manner. Clinical and behavioral observations were made daily, and radiological and histopathological evaluations were performed at 4, 10, and 16 weeks postimplantation. Defects implanted with HCCP showed progressive bone regeneration and bridging of the defect without adverse histological events. No signs of infection or inflammation associated with the implant material were observed in all animals that received HCCP implantation. A radiographic assessment performed at 16 weeks post-implantation showed significantly higher bone density and volume in defects implanted with HCCP compared to PLGA/HA. No statistically significant difference was observed in bone density and volume between HCCP and autologous bone. These findings demonstrate that HCCP is biocompatible, osteoconductive, and capable of promoting bone regeneration in vivo; therefore, it is suitable for both tissue engineering and the repair of critical-sized bone defects.

Original languageEnglish (US)
Pages (from-to)111-120
Number of pages10
JournalBioResearch Open Access
Volume8
Issue number1
DOIs
StatePublished - Jul 1 2019

Fingerprint

Polymers
Bone
Repair
Carbohydrates
Bone and Bones
Defects
Bone Regeneration
Bone Density
Polyglactin 910
Hyaluronic Acid
Tissue Engineering
Thigh
Tissue engineering
Rabbits
Inflammation
Safety
Animals
Infection
polylactic acid-polyglycolic acid copolymer

Keywords

  • bone graft substitute
  • critical-sized defect
  • hyper-crosslinked carbohydrate polymer
  • tissue engineering

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hyper-Crosslinked Carbohydrate Polymer for Repair of Critical-Sized Bone Defects. / Koleva, Plamena M.; Keefer, James H.; Ayala, Alexandria M.; Lorenzo, Isabela; Han, Christine E.; Pham, Kristen; Ralston, Stacy E.; Kim, Kee D.; Lee, Charles C.

In: BioResearch Open Access, Vol. 8, No. 1, 01.07.2019, p. 111-120.

Research output: Contribution to journalArticle

Koleva, PM, Keefer, JH, Ayala, AM, Lorenzo, I, Han, CE, Pham, K, Ralston, SE, Kim, KD & Lee, CC 2019, 'Hyper-Crosslinked Carbohydrate Polymer for Repair of Critical-Sized Bone Defects', BioResearch Open Access, vol. 8, no. 1, pp. 111-120. https://doi.org/10.1089/biores.2019.0021
Koleva, Plamena M. ; Keefer, James H. ; Ayala, Alexandria M. ; Lorenzo, Isabela ; Han, Christine E. ; Pham, Kristen ; Ralston, Stacy E. ; Kim, Kee D. ; Lee, Charles C. / Hyper-Crosslinked Carbohydrate Polymer for Repair of Critical-Sized Bone Defects. In: BioResearch Open Access. 2019 ; Vol. 8, No. 1. pp. 111-120.
@article{2cc1cdef231f4448861367f23d16cc17,
title = "Hyper-Crosslinked Carbohydrate Polymer for Repair of Critical-Sized Bone Defects",
abstract = "This study evaluated the safety and efficacy of a novel hyper-crosslinked carbohydrate polymer (HCCP) for the repair of critical-sized bone defects in comparison to two alternative treatments: autologous bone and poly(lactide-co-glycolide) with hyaluronic acid (PLGA/HA). Bilateral critical-sized defects were created in the lateral femoral condyles of skeletally mature New Zealand White rabbits, and they were subsequently implanted with HCCP, PLGA/HA, or autologous bone in a randomized manner. Clinical and behavioral observations were made daily, and radiological and histopathological evaluations were performed at 4, 10, and 16 weeks postimplantation. Defects implanted with HCCP showed progressive bone regeneration and bridging of the defect without adverse histological events. No signs of infection or inflammation associated with the implant material were observed in all animals that received HCCP implantation. A radiographic assessment performed at 16 weeks post-implantation showed significantly higher bone density and volume in defects implanted with HCCP compared to PLGA/HA. No statistically significant difference was observed in bone density and volume between HCCP and autologous bone. These findings demonstrate that HCCP is biocompatible, osteoconductive, and capable of promoting bone regeneration in vivo; therefore, it is suitable for both tissue engineering and the repair of critical-sized bone defects.",
keywords = "bone graft substitute, critical-sized defect, hyper-crosslinked carbohydrate polymer, tissue engineering",
author = "Koleva, {Plamena M.} and Keefer, {James H.} and Ayala, {Alexandria M.} and Isabela Lorenzo and Han, {Christine E.} and Kristen Pham and Ralston, {Stacy E.} and Kim, {Kee D.} and Lee, {Charles C.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1089/biores.2019.0021",
language = "English (US)",
volume = "8",
pages = "111--120",
journal = "BioResearch Open Access",
issn = "2164-7860",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Hyper-Crosslinked Carbohydrate Polymer for Repair of Critical-Sized Bone Defects

AU - Koleva, Plamena M.

AU - Keefer, James H.

AU - Ayala, Alexandria M.

AU - Lorenzo, Isabela

AU - Han, Christine E.

AU - Pham, Kristen

AU - Ralston, Stacy E.

AU - Kim, Kee D.

AU - Lee, Charles C.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - This study evaluated the safety and efficacy of a novel hyper-crosslinked carbohydrate polymer (HCCP) for the repair of critical-sized bone defects in comparison to two alternative treatments: autologous bone and poly(lactide-co-glycolide) with hyaluronic acid (PLGA/HA). Bilateral critical-sized defects were created in the lateral femoral condyles of skeletally mature New Zealand White rabbits, and they were subsequently implanted with HCCP, PLGA/HA, or autologous bone in a randomized manner. Clinical and behavioral observations were made daily, and radiological and histopathological evaluations were performed at 4, 10, and 16 weeks postimplantation. Defects implanted with HCCP showed progressive bone regeneration and bridging of the defect without adverse histological events. No signs of infection or inflammation associated with the implant material were observed in all animals that received HCCP implantation. A radiographic assessment performed at 16 weeks post-implantation showed significantly higher bone density and volume in defects implanted with HCCP compared to PLGA/HA. No statistically significant difference was observed in bone density and volume between HCCP and autologous bone. These findings demonstrate that HCCP is biocompatible, osteoconductive, and capable of promoting bone regeneration in vivo; therefore, it is suitable for both tissue engineering and the repair of critical-sized bone defects.

AB - This study evaluated the safety and efficacy of a novel hyper-crosslinked carbohydrate polymer (HCCP) for the repair of critical-sized bone defects in comparison to two alternative treatments: autologous bone and poly(lactide-co-glycolide) with hyaluronic acid (PLGA/HA). Bilateral critical-sized defects were created in the lateral femoral condyles of skeletally mature New Zealand White rabbits, and they were subsequently implanted with HCCP, PLGA/HA, or autologous bone in a randomized manner. Clinical and behavioral observations were made daily, and radiological and histopathological evaluations were performed at 4, 10, and 16 weeks postimplantation. Defects implanted with HCCP showed progressive bone regeneration and bridging of the defect without adverse histological events. No signs of infection or inflammation associated with the implant material were observed in all animals that received HCCP implantation. A radiographic assessment performed at 16 weeks post-implantation showed significantly higher bone density and volume in defects implanted with HCCP compared to PLGA/HA. No statistically significant difference was observed in bone density and volume between HCCP and autologous bone. These findings demonstrate that HCCP is biocompatible, osteoconductive, and capable of promoting bone regeneration in vivo; therefore, it is suitable for both tissue engineering and the repair of critical-sized bone defects.

KW - bone graft substitute

KW - critical-sized defect

KW - hyper-crosslinked carbohydrate polymer

KW - tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85069634504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069634504&partnerID=8YFLogxK

U2 - 10.1089/biores.2019.0021

DO - 10.1089/biores.2019.0021

M3 - Article

AN - SCOPUS:85069634504

VL - 8

SP - 111

EP - 120

JO - BioResearch Open Access

JF - BioResearch Open Access

SN - 2164-7860

IS - 1

ER -